CNBX Pharmaceuticals
About CNBX Pharmaceuticals
CNBX Pharmaceuticals is a publicly traded company (CNBX: OTCQB) and developer of the world’s first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on the company’s novel and proprietary formulation CNBX RCC-33.
Find CNBX Pharmaceuticals Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
0-500K
Pharmaceutical Manufacturing
11-50 employees
Public Company
Bethesda, Maryland
United States
Frequently Asked Questions about
What is CNBX Pharmaceuticals's industry?
CNBX Pharmaceuticals operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.
How many employees does CNBX Pharmaceuticals have?
CNBX Pharmaceuticals has approximately 11-50 employees employees.
Where is CNBX Pharmaceuticals's based?
CNBX Pharmaceuticals is based in Bethesda, Maryland, United States.
Is CNBX Pharmaceuticals publicly listed?
Yes. CNBX Pharmaceuticals is a publicly traded company.
How can I contact CNBX Pharmaceuticals's investor relations team?
You can reach CNBX Pharmaceuticals’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.